UCSF researchers have safely transplanted a woman’s stem cells into her growing fetus, leading to the live birth of an infant with a normally fatal fetal condition, alpha thalassemia, the first patient in the world’s first clinical trial using blood stem cells transplanted prior to birth.

UCSF researchers have safely transplanted a woman?s stem cells into her growing fetus, leading to the live birth of an infant with a normally fatal fetal condition.

https://www.ucsf.edu/news/2018/05/410436/ucsf-first-utero-stem-cell-transplant-clinical-trial

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →